Cobimetinib

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 488 publications

Inhibitory effect of lonafarnib on anaplastic thyroid carcinoma cell lines and a nude mouse xenograft model

Inhibitory effect of lonafarnib on anaplastic thyroid carcinoma cell lines and a nude mouse xenograft model

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: June 08, 2026

Stability of extemporaneously compounded cobimetinib oral suspensions.

Stability of extemporaneously compounded cobimetinib oral suspensions.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 06, 2026

Nivolumab plus ipilimumab and cobimetinib in previously treated microsatellite-stable/DNA mismatch repair-proficient metastatic colorectal cancer: the phase II CheckMate 142 trial.

Nivolumab plus ipilimumab and cobimetinib in previously treated microsatellite-stable/DNA mismatch repair-proficient metastatic colorectal cancer: the phase II CheckMate 142 trial.

Journal: ESMO gastrointestinal oncology
Published: April 30, 2026

Diagnosis and Management of Extranodal Rosai-Dorfman Disease Isolated to the Thoracic Spine: Systematic Review and Illustrative Case.

Diagnosis and Management of Extranodal Rosai-Dorfman Disease Isolated to the Thoracic Spine: Systematic Review and Illustrative Case.

Journal: World neurosurgery
Published: April 29, 2026

Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression.

Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression.

Journal: Science translational medicine
Published: April 22, 2026

Electrospun Zn-cobimetinib-levofloxacin-PVA/PVP nanofibers for skin-targeted anticancer and antimicrobial applications.

Electrospun Zn-cobimetinib-levofloxacin-PVA/PVP nanofibers for skin-targeted anticancer and antimicrobial applications.

Journal: RSC advances
Published: April 22, 2026

Targeting MEK1/2 inhibits mitochondrial respiration and redox homeostasis in resistant rectal cancer.

Targeting MEK1/2 inhibits mitochondrial respiration and redox homeostasis in resistant rectal cancer.

Journal: Journal of bioenergetics and biomembranes
Published: March 08, 2026

Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells.

Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells.

Journal: Journal of proteome research
Published: February 25, 2026

Azetidines in medicinal chemistry: emerging applications and approved drugs.

Azetidines in medicinal chemistry: emerging applications and approved drugs.

Journal: Future medicinal chemistry
Published: January 05, 2026

CHOROIDAL INFILTRATION IN ERDHEIM-CHESTER DISEASE: A CASE SERIES.

CHOROIDAL INFILTRATION IN ERDHEIM-CHESTER DISEASE: A CASE SERIES.

Journal: Retinal cases & brief reports
Published: December 22, 2025

Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?

Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?

Journal: Expert opinion on investigational drugs
Published: December 05, 2025

Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy.

Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Showing 1-12 of 488

Last Updated: 06/30/2026